1 DSM-5 AND ASAM CRITERIA Presented by Jaime Goffin, LCSW
2 MODULE 1: GOALS & OBJECTIVES What is your experience with using ASAM and DSM 5 criteria? What are your learning expectations for today?
3 GOAL FOR TRAINING To develop and/or enhance the knowledge and skills to make more informed and accurate clinical decisions and write concise clinical justifications for those decisions using the DSM-5 and ASAM Criteria 3 rd Edition.
4 OBJECTIVES Identify and explain rationale and benefits of using the ASAM Criteria to make patient placements Identify characteristics and differentiate between various levels of care Identify and differentiate between ASAM s six dimensions of assessment Identify information to formulate a dimension risk rating Learn how dimension risk rating and clinical justification directly drive treatment planning
5 CRITICAL THINKING Practitioners who are willing to call into question the assumptions underlining their customary, habitual ways of thinking and acting, and are ready to think and act differently on the basis of critical questioning...
6 TRAINING IS NOT Designed to answer all of your questions regarding the assessment, placement and treatment of persons with addictive disorders Sufficient to make you competent in the use of ASAM criteria, but rather an introduction to it. Further practice, training and supervision is required to learn how to use the criteria successfully.
7 MODULE 2: CHALLENGES FACING THE FIELD 1. Standardization in the collection of client information 2. Consistency of the interpretation of data collected for patient placement and treatment planning purposes 3. Matching of appropriate evidence based, proven and effective treatment interventions to the client s identified problems 4. Correct implementation of evidenced based interventions 5. Development and implementation of policies and procedures to monitor the above.
8 MODULE 3: RATIONALE & BENEFITS OF STANDARDIZED ASSESSMENT CRITERIA
9 WHAT DOES THE RESEARCH SAY? Clients that are mismatched to treatment have lower retention rates and poorer outcomes. Less treatment is NOT Good. More treatment is NOT Good.
10 WHAT S HAPPENING IN SOME PROGRAMS Client s are being referred to wrong levels of care. Client s assessed are referred to, and treated in the agency conducting the assessment Assessments don t justify the recommendations being made. Clinical justifications are provided
11 WHAT IF.. We asked 200 Counselors to make a patient placement decision and provide a clinical justification for that decision? All given the same case.
12 WHAT DO YOU THINK HAPPENED?
13 BENEFITS OF USING EVIDENCE BASED CRITERIA Improve Performance and Treatment Outcomes Increase Motivation, Engagement and Retention Rates More Efficient and Effective Utilization Reviews Use of a common language
14 IMPORTANT! Tools and Criteria s are NOT substitutes for GOOD Clinical Judgment. Tools and Criteria s support, guide and enhance GOOD Clinical Judgment.
15 MODULE 4: ASAM CRITERIA The ASAM Criteria describes in detail an IDEAL continuum of care with the various services and interventions provide at each levels.
16 HISTORY: UNDERLYING PRINCIPLES CLINICAL CARE Complications-driven Treatment No diagnosis of Substance Use Disorder Treatment of Complications of the addiction with no continuing care Relapse Triggers treatment of complications only. Companies.net
17 DIAGNOSIS, PROGRAM-DRIVEN TREATMENT Diagnosis determines treatment Treatment is the primary program and aftercare Relapse- triggers a repeat of the program Companies.net
18 INDIVIDUALIZED, CLINICALLY-DRIVEN
19 CLIENT-DIRECTED, OUTCOME INFORMED
20 GUIDING PRINCIPLES OF THE ASAM CRITERIA 2013 Moving from one-dimensional to multidimensional assessment
21 PRINCIPLE #2 Moving from program-driven to clinically driven and outcomes-driven treatment
22 PRINCIPLE #3 Moving from fixed length of service to variable length of service
37 SUD CRITERIA PRIMARILY IN SEVERE DESIGNATION ONLY The Big Five: Wanting to cut down/unable to do so Craving with compulsion to use Sacrifice activities to use Failure at role fulfillment due to use Withdrawal symptoms
38 CRITERIA PREVALENT IN MILD & MODERATE GROUPS Unplanned use Time spent using Medical/psych. consequences of use Use where impairment is dangerous Interpersonal conflicts Legal problems and use to relieve emotional distress similar in distribution to these
39 CLINICAL IMPLICATIONS Most of those in the mild designation can probably benefit from moderation and harm reduction strategies Those in the severe designation will require more intensive and extended services where abstinence is essential to recovery The moderate group may have characteristics that fit the mild or severe characteristics.
40 SEVERITY SCALE DSM-5 The severity of each Substance Use Disorder is based on: 0 criteria or 1 criteria: No diagnosis 2-3 criteria: Mild Substance Use Disorder 4-5 criteria: Moderate Substance Use Disorder 6 or more criteria: Severe Substance Use Disorder
41 EXAMPLE IN DSM Alcohol Use Disorder, severe 303 Alcohol Intoxication with use disorder, severe Alcohol Withdrawal, with perceptual disturbances Other Alcohol-Induced Disorder Unspecified Alcohol-Related Disorder
42 SEVERITY AN COURSE SPECIFIERS In early remission: Full criteria for SUD was previously met None of the criteria for SUD have been met for at least 3 months, but for less than 12 months Except for Criteria 4 (Craving or a strong desire to use)
43 IN A SUSTAINED REMISSION: Full criteria for SUD were previously met None of the criteria for SUD have been met at any time during a period of 12 months or longer, Except for Criteria 4 (Craving or a strong desire to use)
44 IN A CONTROLLED ENVIRONMENT This additional specifier is used if the individual is in an environment where access to alcohol or controlled substances is restricted. Examples of these environments are closely supervised and substance-free jails, therapeutic communities and locked hospital units.
45 HOW TO CODE Diagnosis code for specific substance such as Alcohol Use, followed by any medical conditions, psychosocial stressors, followed by a severity rating of mild, moderate or severe based on criterion met. Other specifiers would include in early remission, sustained remission, on maintenance therapy and in controlled environment.
46 DIAGNOSTIC STRATEGIES Assessing for substance use disorder: In assessing for substance use disorder, one initially attempts to determine whether the patient s substance use is causing negative consequences. If such consequences are significant and recurrent in a 12 month-period, then diagnosis of substance use disorder is warranted.
47 DIAGNOSTIC STRATEGIES CONT. Even if client does not meet criteria for substance use disorder, there may be substance-induced withdrawal or intoxication; or variety of substance-induced disorders including anxiety, depression, psychosis, sleep disorder or sexual dysfunction.
48 MODULE 6: WHAT S NOT NEW IN ASAM The six assessment dimensions The overall levels of care (though not Roman numerals) for addiction management The decision rules, which link Intensity of Service back to the Severity of Illness maintained except for some updates in Withdrawal Management ( Detox )
49 WHAT S NEW IN ASAM New Title: The ASAM Criteria Treatment Criteria for Addictive, Substance- Related, and Co-Occurring Conditions Shift away from placement criteria to treatment criteria: it s more than just placement
50 WHAT S NEW IN ASAM Diagnostic Admission Criteria terminology changed to be compatible with DSM-5 Section on working with managed care Table of contents Re-ordered to be more user-friendly Follows the flow from Historical Foundations to Guiding Principles to Assessment, Service Planning, and Placement decisions
51 WHAT S NEW IN ASAM Adolescent Criteria Still separate criteria for adolescents Consolidated Adult & Adolescent content on principles to minimize redundancy, while preserving adolescent-specific content
52 WHAT S NEW IN ASAM Appendices Withdrawal Management instruments Dimension 5 constructs Glossary
53 WHAT S NEW IN ASAM Withdrawal Management The wording in the Levels of Care Former section Detoxification becomes Withdrawal Management Levels are now called WM-1, WM-2, WM-3, and WM-4 New approaches described to support increased use of less intensive levels of care for safe/effective management of withdrawal
54 WHAT S NEW IN ASAM Withdrawal Management New approaches described to support increased use of less intensive levels of care for safe/effective management of withdrawal A broader range of severity of withdrawal syndromes is discussed in The Criteria as being able to be safely and appropriately managed on an outpatient basis
55 WHAT S NEW IN ASAM Updated/revised terminology Contemporary, strength-based, recovery oriented: dual diagnosis becomes co-occurring disorders inappropriate use of substances becomes high risk use of substances
56 WHAT S NEW IN ASAM Opioid use disorder specialized services Opioid Maintenance Therapy (OMT) becomes Opioid Treatment Services (OTS) Opioid antagonist medication (naltrexone) Opioid agonist medications (methadone, buprenorphine) Their use in OTPs (regulated Opioid Treatment Programs for methadone) or in office-based opioid treatment (OBOT for buprenorphine)
57 NEW CONTENT AND SECTIONS Additional text to improve application to address addiction treatment for Special Populations: Older Adults Persons in Safety Sensitive Occupations Parents with Children and Pregnant Women Persons in the Criminal Justice System (CJS)
58 NEW CONTENT AND SECTIONS Additional text to address treatment of conditions not traditionally included in specialty addiction treatment services: Tobacco Use Disorder Gambling Disorder
59 NEW CONTENT AND SECTIONS Revision of the text to address emerging issues: Healthcare Reform and the integration of addiction treatment into general medical care The role of physicians on the care team, addiction specialist physicians in particular (addiction medicine physicians, addiction psychiatrists)
60 NEW CONTENT AND SECTIONS Inclusion of Recovery Oriented System of Care to facilitate understanding of addiction treatment with a recovery oriented chronic disease management continuum, rather than as a repeated, disconnected acute episodes of treatment for acute complications of addiction and/or repeated and disconnected admissions to programs that employ rigid lengths of stay in which patients are placed.
61 NEW CONTENT AND SECTIONS A new section on Gambling Disorder that is consistent with ASAM s definition of addiction Pathological pursuit of reward or relief can involve not just the use of psychoactive substances but other certain behaviors.. Tobacco Disorder chapter to reflect on the treatment field s inconsistencies in, and even ambivalence about, viewing this addiction as similar to alcohol and substances.
68 MATCHING DIMENSIONAL SEVERITY Step 1: Risk of Imminent danger Step 2: Determine risk rating in each dimension Step 3: Identify appropriate types of services Step 4: Development of initial treatment plan Step 5: Ongoing Utilization Management throughout continuum of care
69 DIMENSION 1: ACUTE INTOXICATION AND/OR WITHDRAWAL POTENTIAL What risk is associated with the patient s current level of acute intoxication? Are intoxication management services needed? Is there significant risk of severe withdrawal symptoms, seizures or medical complications? Are there current signs of withdrawal? Standardized withdrawal scale score? Vital signs? Does the patient have supports to assist in ambulatory withdrawal management?
70 DIMENSION 2: BIOMEDICAL CONDITIONS AND COMPLICATIONS Are there current physical illnesses, other withdrawal that need to be addressed? Are there chronic conditions that need stabilization or ongoing disease management? Is there a communicable disease present? Is the patient pregnant, what is her pregnancy history?
71 DIMENSION 3: EMOTIONAL, BEHAVIORAL, COGNITIVE COMPLICATIONS Are there current psychiatric illnesses or psychological, behavioral, emotional or cognitive problems that need to be addressed? Are there chronic conditions that affect treatment such as bipolar or anxiety? Do any emotional, behavioral, or cognitive signs or symptoms appear to be an expected part of the addictive disorder?
72 DIMENSION 3CONT. Are they severe enough to warrant specific mental health treatment, even if symptoms are caused by substance use? Is the patient able to manage the activities of daily living? Can he or she cope with any emotional, behavioral or cognitive problems?
73 DIMENSION 3 RISK DOMAINS Dangerousness/Lethality Interference with Addiction Recovery Efforts Social Functioning Ability for Self-Care Course of Illness
74 DIMENSION 4: READINESS TO CHANGE How aware is the patient of the relationship between his or her alcohol, tobacco, or other drug use or behaviors involved in the pathological pursuit of reward or relief and his or her negative life consequences? How ready, willing, or able does the patient feel to make changes? How much does the patient feel in control of his or her treatment services? Assess each treatment issue for separate stage of change.
75 DIMENSION 5: RELAPSE/CONTINUED USE Historical Pattern of Use Pharmacologic Responsivity External Stimuli Responsivity Cognitive and Behavioral Measures of Strengths and Weaknesses What are your policy and procedures to deal with Dim 5 situations?
76 DIMENSION 5: RELAPSE, CONTINUED USE OR POTENTIAL Is the patient in immediate danger of continued severe mental health distress and/or alcohol, tobacco and/or drug use? Does the patient have any recognition or understanding of, or skills in coping with his or her addictive, co-occurring, or mental disorder? Have addiction and/or psychotropic medications assisted in recovery before? What are the person s skills in coping with protracted withdrawal, cravings, or impulses?
77 DIMENSION 5 CONT. How well can the patient cope with negative effects, peer pressure, and stress without recurrence of addictive thinking and behavior? How severe are the problems and further distress that may continue or reappear if the patient is not successfully engaged in treatment? How aware is the patient of relapse triggers and skills to control addiction impulses or impulses to harm self or others?
78 DIMENSION 6: RECOVERY ENVIRONMENT Do any family members, significant others, living situations, or school work situations pose a threat to the patient s safety or engagement in treatment? Does the individual have supportive friendships, financial resources, or educational or vocational resources that can increase the likelihood of successful recovery? Are there legal, vocational, regulatory (eg professional licensure), social service agency, or criminal justice mandates that may enhance the person s motivation for engagement in treatment if indicated? Are there transportation, childcare, housing, or employment issues that need to be clarified and addressed?
79 DECISION HIERARCHY Dimensions 1, 2, 3, generally help indicate Inpatient or Outpatient Dimensions 4, 5, 6 generally help indicate the intensity of outpatient ( there are often times that Dim 5 and 6 will indicate inpatient treatment. Each dimension receives a Risk Rating
80 CASE PRACTICE Dimension Severity? Services Needed? Level of Care Recommendation?
81 LENGTH OF STAY AND DISCHARGE Clinically Driven NOT Program Driven
82 LOC RECOMMENDATION PROCESS Interpret the Assessment Information Select Risk Rating and Write Clinical Justification for each Dim Asses if the Risk Status on some of Dimensions Influence/Increase the risk of other Dimensions Assess Recovery & Other Support Services Available Level of Care/Service Recommendation Treatment Planning
83 5 M S Motivate - Dimension 4 Manage All Six Dimensions Medication Dimensions 1, 2, 3, 5 Meetings Dimensions 2, 3, 4, 5, 6 Monitor- All Six Dimensions
84 SEVERITY OF ASSESSMENT THE 3 H S HISTORY HERE AND NOW HOW WORRIED NOW
85 CLINICAL JUSTIFICATION Risk Rating Clinical Justification- each dimensional summary includes a statement indicating severity/risk rating. Level of Care Clinical Justification
86 LEVEL OF CARE RECOMMENDATION 1. Clinical justification is a summary of the evidence that supports and justifies a clinical decision. 2. Clinical justifications generally include symptoms that meet established criteria: ASAM, DSM5 other tools Treatment professionals are responsible for documenting clinical decisions and justifying them with evidence.
87 THANK YOU!
88 REFERENCES American Psychiatric Association, Diagnostic and Statistical manual of Mental Disorders, Fifth Edition, American Society of Addiction Medicine, 3 rd edition, Mee-Lee, David (2013): The New edition of the ASAM Criteria: What s New and Why Counselor Vol. 14. No.4 pp August 2013 Mee-Lee, David (2013): How to Really Use the New Edition of The ASAM Criteria: What To Do & What Not to Do. Counselor Vol. 14. No. 6 pp December 2013.
Clinical Evaluation: Treatment Planning Goals and Objectives 1) Define Treatment Planning 2) Understanding of Correlation Between Assessment and Treatment Planning 3) Overview of Treatment Planning Process
Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5
Addiction Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine Twitter: @rcwallermd Objectives Understand the Concept of Addiction Survival FOOD WATER DOPAMINE
(DMHAS) Fee for Service (FFS) ANNEX A1 DMHAS ASAM SERVICE DESCRIPTIONS Please carefully review the Service Descriptions that are included in the DMHAS FFS Initiatives in this Annex A1 contract section.
Appendix F Federation of State Medical Boards Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office SECTION I: PREAMBLE The (name of board) recognizes that the prevalence of addiction
Treatment Alternatives for Substance Use Disorders Dean Drosnes, MD, FASAM Associate Medical Director Director, Chronic Pain and SUD Program Caron Treatment Centers 1 Disclosure The speaker has no conflict
Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance
The ASAM Criteria Introduction [ June 2017] The ASAM Criteria The ASAM Criteria: Treatment Criteria for Addictive, Substance- Related, and Co-Occurring Conditions American Society of Addiction Medicine
Reducing Stigma and improving access to Medication Assisted Treatment for Drug and Alcohol use disorders Presented by: Jim Scarpace ; LCPC Who is Gateway Alcohol & Drug Treatment? Largest Provider of Substance
Assessment Clinical Steps To ensuring the needs Of your clients are Identified Session Objectives Learn what the best strategies are to determine which potential drug court clients are most suitable for
Effective Treatment: Doing the Right Thing, In the Right Way Terrence D Walton, MSW, ICADC Monitor Manage Impact 1. Understand the Treatment Field, including Evidenced Based Practices 2. Understand Your
Child and Adolescent Screening and Assessment Tools Randall Stiles, PhD. State of Nevada Division of Child and Family Services The views, opinions, and content expressed in this presentation do not necessarily
FY17 SCOPE OF WORK TEMPLATE Name of Program/Services: Medication-Assisted Treatment: Buprenorphine Procedure Code: Modification of 99212, 99213 and 99214: 99212 22 99213 22 99214 22 Definitions: Buprenorphine
General Principles for the Use of Pharmacological Agents for Co- Occurring Disorders Individuals with co-occurring mental and substance use disorders (COD) are common in behavioral and primary health settings
The Time is Here: Differential Diagnosis and Coding Using the DSM 5 and ICD 10 Diane Snow, PhD, RN, PMHNP-BC, FAANP, FIAAN University of Texas at Arlington College of Nursing and Health Innovation IntNSA
Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry In broad terms, substance use disorders occur when a substance is used in a compulsive manner with a lack of control over
Serious Mental Illness and Opioid Use Disorder Serious Mental Illness and Opioid Use Disorders Arthur Robin Williams, MD MBE Columbia University, Department of Psychiatry Nick Szubiak, MSW, LCSW Director,
Chapter 7 Screening and Assessment Screening And Assessment Starting the dialogue and begin relationship Each are sizing each other up Information gathering Listening to their story Asking the questions
DSM-5 UPDATE Supplement to DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION October 2017 DSM-5 Update October 2017 Supplement to Diagnostic and Statistical Manual of Mental Disorders,
Substance Use Disorders in Primary Care Jin Hee Yoon-Hudman, MD Assistant Vice President, Medical Director, Behavioral Health Healthfirst Fall Symposium Prevention as a Priority in Value-Based Healthcare,
Bipolar Disorder Clinical Practice Guideline Summary for Primary Care DIAGNOSIS AND CLINICAL ASSESSMENT Bipolar Disorder is categorized by extreme mood cycling; manifested by periods of euphoria, grandiosity,
2017 OPIOID TREATMENT PROGRAM PROGRAM DESCRIPTIONS Contents Opioid Treatment Program Core Program Standards... 2 Court Treatment (CT)... 2 Detoxification... 2 Day Treatment... 3 Health Home (HH)... 3 Integrated
The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine March 10, 2016 Objectives Review current state of opioid crisis in Maine Briefly review physiology of
112 Addictive Disorders Counseling Addictive Disorders Counseling Degrees, Certificates and Awards Associate in Arts: Alcohol and Drug Counseling Certificate of Achievement: Alcohol and Drug Counseling
Sex: Ethnic Group: Marital Status: Occupation: Education: Multiaxial Diagnosis Axis I: Clinical Disorders / Other Conditions That May Be a Focus of Clinical Attention Diagnostic Code DSM-IV Name Axis II:
THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.
People drink for all sorts of reason. Some reasons are to socialize, celebrate and relax. Other times people use alcohol as a form of self-medication to help them manage stress, anxiety or to use it to
Medical Necessity Criteria 2017 The New Directions Medical Necessity Criteria have been revised. The new version will be effective January 1, 2017. See https://www.ndbh.com/providers/behavioralhealthplanproviders.aspx.
MULTISYSTEMIC THERAPY (MST) Multisystemic Therapy (MST) - Youth Program Description Multisystemic therapy (MST) is an intensive family and community-based treatment that addresses multiple aspects of serious
Reducing Stigma and improving access to Drug and Alcohol Treatment Presented by: Jim Scarpace ; LCPC Who is Gateway Alcohol & Drug Treatment? Largest Provider of Substance Abuse Treatment in Illinois Locations
ICD-10 Tobacco Billing Guide ICD-10 and Tobacco Common Diagnosis Codes and Tips for Coding Nicotine Use/ Dependence Tobacco use is the leading cause of preventable disease and death in the United States,
Recovery-Oriented Systems of Care (ROSC) and Comprehensive Community Services Langeston Hughes, CCS Coordinator Danielle Graham-Heine, CCS Coordinator October 27, 2016 What is CCS Publicly-operated behavioral
AMBULATORY WITHDRAWAL MANAGEMENT Erin Kinard, MS, NCC, LCADC CASAT March 21, 2017 The views, opinions, and content expressed in this presentation do not necessarily reflect the views, opinions, or policies
How to Start Strong and Keep Going SCOPE AND SEQUENCE An Educational Video Based on Best Practices in Recovery Management from For more information about this program, visit hazelden.org/bookstore or call
British Journal of Addiction (1990) 85, 1403-1408 COMMENTARY Addiction: definition and implications AVIEL GOODMAN, M.D. Minnesota Institute of Psychiatry, 1347 Summit Avenue, St Paul, MN 55105, USA Abstract
Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care CLINICAL ASSESSMENT AND DIAGNOSIS (ADULTS) Obsessive-Compulsive Disorder (OCD) is categorized by recurrent obsessions,
CONTENT OUTLINES AND KSAS Bachelors Social Work Licensing Examination What are KSAs? A KSA is a knowledge, skills, and abilities statement. These statements describe the discrete knowledge components that
CHILD Multi Systemic Therapy Problem Sexual Behavior PROGRAM DESCRIPTION Multi Systemic Therapy Problem Sexual Behavior (MST PSB) is an adaptation of the evidenced based treatment model MST to target adolescents
ICD-10-CM Specialized Coding Training http://publichealth.nc.gov/lhd/icd10/training.htm Behavioral Health Course For Local Health Departments and Rural Health Unit 1 1 Behavioral Health Training Objectives
CONTENT OUTLINES AND KSAS Masters Social Work Licensing Examination What are KSAs? A KSA is a knowledge, skills, and abilities statement. These statements describe the discrete knowledge components that
1 Treatment Planning Tools ASI-MV These Treatment Planning Tools summarize the client s self-reported data from the ASI-MV. When used in conjunction with the Problem Lists & Key Clusters and the ASI-MV
Understanding Addiction: Why Can t Those Affected Just Say No? 1 The Stigma of Addiction There continues to be a stigma surrounding addiction even among health care workers. Consider the negative opinions
Building the Evidence Based Intensive OP Service Presenter: Thomas L. Moore LMSW, LLP, CAADC, CCS September 23 2014 1 # 33 Comprehensive Assessment # 30 Application of SUD Diagnosis to treatment recommendations
I. Definition of Service: ACUTE INPATIENT TREATMENT Acute inpatient hospitalization represents the most intensive level of psychiatric care. Multidisciplinary assessments and multimodal interventions are
2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted
Medical Necessity Criteria Guidelines Effective Date: December 1, 2016 Updated September 30, 2016 Medical Necessity Criteria Guidelines 2007-2017 Magellan Health, Inc. Table of Contents 2007-2016 Magellan
Overview of Adolescent Substance Abuse & Treatment Joan E. Zweben, Ph.D. Executive Director, EBCRP Clinical Professor of Psychiatry, UCSF PREP Program Training June 23, 2011 Adolescent Substance Use Critical
START Call 911 Chester County Drug & Alcohol Services Map Are you in a lifethreatening situation/ condition (medical or psychiatric)? Do you need ambulance assistance? Go to the nearest hospital/er You
Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons Marianna Corona Jennifer Foley September 12, 2017 Learning Objectives 2017 Improving Family Outcomes
V. EVIDENCE-BASED APPROACHES TO TREATING ADOLESCENT SUBSTANCE USE DISORDERS R esearch evidence supports the effectiveness of various substance abuse treatment approaches for adolescents. Examples of specific
College Health IPA (CHIPA) National Medical Necessity/Level of Care Criteria College Health IPA (CHIPA) uses its Medical Necessity Criteria (MNC) as guidelines, not absolute standards, and considers them
Substance Abuse Group Therapy Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Chapter 1 This natural propensity in humans makes group therapy a powerful
UMASS TOBACCO TREATMENT SPECIALIST CORE TRAINING Course Description Goals and Learning Objectives 55 Lake Ave North, Worcester, MA 01655 www.umassmed.edu/tobacco 1 Table of Contents Determinants of Nicotine
Adolescents And Addiction 1) According to the Substance Abuse and Mental Health Services Administration (SAHMSA), over million people over the age of 12 years needed treatment for substance use in 2012.
HOUSE Calls Published by the Alachua County Medical Society Winter 2017 Addiction Medicine Addiction as a Disease Gregory L. Jones, MD, FASAM, FAAF, UF Health Florida Recovery Center Scott A. Teitelbaum,
PAGE: 1 of 6 This medical policy is not a guarantee of benefits or coverage, nor should it be deemed as medical advice. In the event of any conflict concerning benefit coverage, the employer/member summary
BEHAVIORAL H E A L T H T R E A T M E N T Hope for a bright future Providing a comprehensive mental health and addiction treatment continuum for senior adults, adults and adolescents Offering a Comprehensive
Substance Use And Addiction Disorders, Parts 3 & 4 1. Medication Assisted Treatment is: a. used exclusively for marijuana addiction b. the program of choice for chronic relapses c. recommended for multiple
BASIC VOLUME Elements of Drug Dependence Treatment BASIC VOLUME MODULE 1 Drug dependence concept and principles of drug treatment MODULE 2 Motivating clients for treatment and addressing resistance MODULE
SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES
Outpatient Substance Abuse Discharge Process Client Name: CID# Discharge Staff: Discharge Date Please complete the following items when discharging a client from Substance Abuse. Discharge / Transfer Summary
SUBSTANCE USE AND ADDICTION DISORDERS: Part 3: Treatment And Goals Of Therapy Introduction In multiple substance use disorders, the treatment plan and length of the detoxification phase may vary. Previously,
Kaiser Telecare Program for Intensive Community Support Intensive Case Management Exclusively for Members within a Managed Care System 12-Month Customer Report, January to December, 2007 We exist to help
Department of Public Health Bureau of Substance Abuse Services - BSAS Luisa Fundora, MSW Regional Manager BSAS/ MA DPH Bureau of Substance Abuse Services The Bureau of Substance Abuse Services (BSAS) is
PSYCHOLOGICAL DISORDERS CHAPTER 13 MEYERS AND DEWALL OVERVIEW What are Psychological Disorders? Anxiety Disorders, OCD, and PTSD Substance Use and Addictive Disorders Mood Disorders Schizophrenia Additional
KANSAS Kansas State Board of Healing Arts Source: Kansas State Board of Healing Arts Approved: October 17, 1998 GUIDELINES FOR THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF PAIN Section 1: Preamble
THE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved You can contact this author at email@example.com
Program Topics Offered by the Office of Education and Regional Programming/Western Psychiatric Institute and Clinic through June 2011 Children and Adolescents ASSUMING THE PARENTAL ROLE WITHIN THE FAMILY:
+ Contingency Management with Adolescents and Their Families Evidencebased approach for treating adolescent substance abuse Promotes positive behaviors and addresses ambivalence Strength- Based, Family-
Ambulatory Intoxication and Withdrawal Management: A Clinical Monograph Revised December 2016 1 Table of Contents I. Ambulatory Intoxication and Withdrawal Management... 3 II. Evaluation and Assessment
Coexisting severe ere mental illness (psychosis) and substance misuse: assessment and management in healthcare settings Clinical guideline Published: 23 March 2011 nice.org.uk/guidance/cg120 NICE 2018.
Evidence-Based Practice Fidelity Site Visit Tools This product was supported by Florida Department of Children and Families Substance Abuse and Mental Health Program Office funding. Evidence-Based Practice
Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
Tapering Opioids Best Practices* Chuck Hofmann, MD, MACP 5 th Annual EOCCO Office Staff and Provider Summit September 28, 2017 Disclosure No Conflicts of Interest to report Learning Objectives Understand
Responding to the Opioid Epidemic Jessica Gray, MD Addiction Medicine Fellow Boston Medical Center ROME New England August 17, 2017 Disclosures for Jessica Gray, MD No conflicts Learning Objectives Describe
Cluster 1 Common Mental Health Problems (mild) You have recently sought help for the first time. You have experienced depression and/or anxiety. This may cause distraction or minor disruption to you as